Skip to main content
Clinical Trials/JPRN-UMIN000016456
JPRN-UMIN000016456
Not Yet Recruiting
N/A

A clinical study for evaluating the efficacy and safety of long-term consumption of the honey vinegar beverage on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertension - A clinical study for evaluating the efficacy and safety of long-term consumption of the honey vinegar beverage on lowering blood pressure

Soiken Inc.0 sites100 target enrollmentAugust 31, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Soiken Inc.
Enrollment
100
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Subjects who need an urgent anti\-hypertensive treatment 2\) Subjects who have a symptom of cerebrovascular diseases 3\) Heart failure patients or subjects who have a history of myocardial infarction 4\) Subjects who have an atrial fibrillation or a severe arrhythmia 5\) Subjects who have a severe renal dysfunction (serum creatinine \>\=2 mg/dl) 6\) Subjects who have severe hepatic, cardiovascular, respiratory disease, endocrine or metabolic disorders 7\) Subjects who have a history of the hypersensitivity or an allergy for test foods in this study 8\) Subjects who have a secondary hypertension 9\) Subjects who regularly take any anti\-hypertensive drug or FOSHU for improving hypertension 10\) For female: Subjects with pregnant or breast feeding , or those who have a plan to be pregnant during the study period 11\) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 12\) Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 13\) Subject deemed unsuitable by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials